Our share price analysis, data and how-to-buy guides cover significant market movements in the most popular UK shares in the FTSE 100, US stocks in the DJIA, commodities, indices, and currency pairs. They are designed to help you make more informed decisions about what to invest in, what to trade, and when to execute currency transactions.


Johnson & Johnson’s Journey to 2030: A Vision for Growth and Value in Healthcare
Healthcare company Johnson & Johnson (NYSE:JNJ) has been a solid investment over the long run. Over the last 10 years, its share price has risen from around $90 to $157. Here, we are going to look at where the S&P 500 healthcare stock could be trading in 2030. Letβs make some share price projections for


How to Trade EURGBP – Expert Guide to Trading Euro Sterling
In our guide to trading EURGBP, we explain what euro sterling trading is, where to do it and how to maximise your chances of making money. If you are overwhelmed by the jargon in the foreign exchange market, and don’t know where to start, this guide to trading EURGBP will help you to understand the


JP Morgan’s Record Heights: Exploring the Potential Peak of a Banking Titan
JP Morgan (NYSE:JPM) is widely regarded as one of the best banks in the world. Founded in 1871, it has been dominating the banking industry for a long time. Recently, JPM stock has been a great investment. Earlier this month, it hit new all-time highs. The question is βΒ how high can it go? How high


Intel’s Surge and Future Prospects: Analyzing the Semiconductor Giant’s Path to 2025
Intel (NASDAQ:INTC) shares have had a great run recently. Over the last year, theyβve climbed from $28 to $43 as demand for semiconductors β and interest in artificial intelligence (AI) investing β has picked up. Here, we look at what Intel shares could be worth in 2025. Letβs dive in. What will Intel shares be


Merck’s Momentum: Analysing the Potential Upswing in this Pharma Giant’s Stock Price
Merck & Co (NYSE:MRK) shares are in a strong uptrend right now. Over the last three months, they have climbed from around $104 to $127. Here, Iβm going to look at analystsβ target price for Merck & Co. Can the pharma stock keep rising? Whatβs driving the Merck share price? Before I reveal the target


IBM’s AI-Powered Surge: Is Now the Time to Sell or Hold IBM Shares?
IBM (NYSE:IBM) stock has been on a tear recently. Over the last year, IBM’s stock price has risen from around $135 to $183 β a gain of approximately 36%. Is it time to sell the stock? Or should investors hold on for further gains? Letβs discuss. IBM is an AI play IBM is having a